|テーマ||“How Does Politics Influence Global Health Policy?: AMR and Pandemic Influenza”|
|17:00-17:05||開会の辞 （NCGMグローバルヘルス政策研究センター長 渋谷健司）|
|17:05-17:10||来賓挨拶 （厚生労働省健康局 結核感染症課長 三宅 邦明）|
|17:10-18:00||特別講演 （香港大学公衆衛生大学院ディレクター・教授Keiji Fukuda)|
|18:55-19:00||閉会の辞（NCGM国際感染症センター長 大曲 貴夫)|
Keiji Fukuda, MD, MPH
Keiji Fukuda is the Director and a Clinical Professor at The University of Hong Kong School of Public Health. He previously worked at the World Health Organization (WHO) in several capacities including Assistant Director-General (ADG) and Special Representative of the Director-General for antimicrobial resistance; ADG for the Health Security and Environment Cluster; and Director of the Global Influenza Programme. Before that, he worked at the U.S. Centers for Disease Control and Prevention (CDC) as the Epidemiology Section Chief, Influenza Branch and as a Medical Epidemiologist in the Viral Exanthems and Herpesvirus Branch, National Center for Infectious Diseases.
Professor Fukuda has been a global public health leader in many areas including health security; emerging infectious diseases including seasonal, avian and pandemic influenza, SARS, MERS and Ebola; antimicrobial resistance; development of the Pandemic Influenza Preparedness Framework; implementation of the International Health Regulations; food safety; and chronic fatigue syndrome. He has considerable experience in epidemiological research and field investigations, media communications and international diplomatic negotiations including those held to establish a historic Heads of State level meeting on antimicrobial resistance at the United Nations in 2016.
He has a BA in Biology, an MD; an MPH; was trained in the Epidemic Intelligence Service at CDC and is certified in internal medicine by the American Board of Internal Medicine.
Makoto Aoki, MD, FACP, FIDSA
Dr. Aoki is a free-lance infectious disease consultant, and also serves as the Adjunct Professor of Medicine, Tokyo Medical University.
He received his MD degree from Hirosaki University School of Medicine in 1979. He completed internal medicine residency in the University of Kentucky School of Medicine followed by an infectious disease fellowship in 1992. He is board-certified in internal medicine and infectious diseases in the United States.
After completion of his fellowship, Dr. Aoki returned to Japan to provide clinical infectious diseases practice at the beginning of the HIV epidemic era in Japan. He once served on advisory committees for AIDS-related medicine with the Ministry of Health, Labor and Welfare in Japan. He also organized numerous collaborative relationships between Japan, the United States of America, and other countries to advance HIV care and management in Japan.
Dr. Aoki is also committed to the education and mentoring of young physicians and other healthcare professionals in the field of clinical infectious diseases in general.
In 2013, he was nominated as one of the ten founders of Japanese medicine by Nikkei Medical Magazine.
Kiyosu Taniguchi, MD, PhD
Dr. Taniguchi is the Director of the Department of Clinical Research, National Mie Hospital, National Hospital Organization in Mie, Japan.
Dr. Taniguchi graduated from the School of Medicine at National Mie University in 1984, and had been trained and worked as a pediatrician at several hospitals for 15 years. Between 1992 and 1995, he engaged in the international collaboration research project in Noguchi Memorial Institute for Medical Research in Ghana.
In 1996, he joined the National Institute of Infectious Diseases (NIID), Tokyo, Japan and had committed the establishment of Infectious Disease Surveillance Center and engaged in the national infectious disease surveillance system and FETP. In 2000, he was dispatched to WHO/HQ/CDS/CSR and worked for international infectious disease surveillance and control program including GOARN and IHR. After coming back to Infectious Disease Surveillance Center, NIID in 2002, he resumed the activities on national infectious disease surveillance and response and experienced a lot of infectious disease outbreaks including SARS, pandemic 2009 and so on.
In 2013, he left NIID and started working at current institution, where in addition to the clinical practice as a pediatrician, he continues to work in the research field on vaccine preventable diseases, surveillance and epidemiology of infectious diseases and various international research program.
Kentaro Iwata, MD, PhD, MSc, FACP, FIDSA, CTH, CIC
Dr. Kentaro Iwata is Professor of Infectious Diseases Risk Communication at the Research Center for Urban Safety and Security, Infectious Diseases Therapeutics of Kobe University Graduate School of Medicine. He also serves as the Chief of the Division of Infectious Diseases as well as the Division of International Healthcare at Kobe University Hospital in Hyogo, Japan.
Hajime Kamiya, MD, MPH, PhD
Dr. Hajime Kamiya is the Senior Researcher and Medical Officer at the Infectious Disease Surveillance Center, National Institute of Infectious Diseases in Tokyo, Japan.
Dr. Kamiya is a native of Japan. He graduated Mie University School of Medicine in 1999 and trained as a pediatrician at St.Luke’s International Hospital in Tokyo. He was board certificated in pediatrics in 2004.
His interest in immunization posted him to a research fellow at University of California San Diego (UCSD), Department of Pediatrics, with the County of San Diego Health and Human Services Agency, Immunization Branch (SDIB). Since 2006, he became graduate student at Rollins School of Public Health, Emory University, Atlanta GA, where he learned the fundamental of epidemiology.
After graduating from Emory University, he joined National Institute of Infectious Diseases, Infectious Disease Surveillance Center in Tokyo as a researcher. In 2012, Dr. Kamiya was accepted as Epidemiology Intelligence Service (EIS) officer at Center for Diseases Control and Prevention (CDC). He was assigned to Meningitis and Vaccine Preventable Disease Branch (MVPDB) and experienced outbreak investigation, evidence based policy making, the strategic planning, interventions and evaluation of the immunization program from a federal government aspect.
Dr. Kamiya returned to his old position in July 2014. Based on his experiences in the United States, Dr. Kamiya is directing his training to be a specialist in immunization field.